Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

2.

Building a European database to gather multi-country evidence on active and latent TB screening for migrants.

Öhd JN, Lönnroth K, Abubakar I, Aldridge RW, Erkens C, Jonsson J, Marchese V, Matteelli A, Menezes D, Zenner D, Hergens MP.

Int J Infect Dis. 2019 Mar;80S:S45-S49. doi: 10.1016/j.ijid.2019.02.041. Epub 2019 Feb 28.

3.

Multidisciplinary approach to prostatitis.

Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, Giuberti R, Granatieri CM, Latino MA, Larganà G, Leli C, Maierna G, Marchese V, Massa E, Matteelli A, Montanari E, Morgia G, Naber KG, Papadouli V, Perletti G, Rekleiti N, Russo GI, Sensini A, Stamatiou K, Trinchieri A, Wagenlehner FME.

Arch Ital Urol Androl. 2019 Jan 18;90(4):227-248. doi: 10.4081/aiua.2018.4.227.

4.

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area.

Rosales-Klintz S, Bruchfeld J, Haas W, Heldal E, Houben RMGJ, van Kessel F, Mandelbaum M, Matteelli A, Migliori GB, Oordt-Speets A, Solovic I, Vašáková M, Verver S, de Vlas SJ, Vonk Noordegraaf-Schouten MJM, de Vries G, Zenner D, van der Werf MJ.

Eur Respir J. 2019 Jan 17;53(1). pii: 1802077. doi: 10.1183/13993003.02077-2018. Print 2019 Jan. No abstract available.

PMID:
30655449
5.

Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study.

Peri AM, Bernasconi DP, Galizzi N, Matteelli A, Codecasa L, Giorgio V, Di Biagio A, Franzetti F, Cingolani A, Gori A, Lapadula G.

BMC Infect Dis. 2018 Dec 20;18(1):690. doi: 10.1186/s12879-018-3609-4.

6.

Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.

Pontarelli A, Marchese V, Scolari C, Capone S, El-Hamad I, Donato F, Moioli R, Girardi E, Cirillo DM, Castelli F, Matteelli A.

Travel Med Infect Dis. 2019 Jan - Feb;27:39-45. doi: 10.1016/j.tmaid.2018.10.015. Epub 2018 Oct 19.

PMID:
30347248
7.

Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS.

Orlando G, Frati ER, Fasolo MM, Bianchi S, Matteelli A, Mazza F, Rizzardini G, Amendola A, Tanzi E.

Hum Vaccin Immunother. 2018 Sep 27:1-7. doi: 10.1080/21645515.2018.1528834. [Epub ahead of print]

8.

Mycobacterium decipiens sp. nov., a new species closely related to the Mycobacterium tuberculosis complex.

Brown-Elliott BA, Simmer PJ, Trovato A, Hyle EP, Droz S, Buckwalter SP, Borroni E, Branda JA, Iana E, Mariottini A, Nelson J, Matteelli A, Toney NC, Scarparo C, de Man TJB, Vasireddy R, Gandhi RT, Wengenack NL, Cirillo DM, Wallace RJ, Tortoli E.

Int J Syst Evol Microbiol. 2018 Nov;68(11):3557-3562. doi: 10.1099/ijsem.0.003031. Epub 2018 Sep 11.

PMID:
30204586
9.

The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol.

Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network.

Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. doi: 10.1186/s40248-018-0141-8. eCollection 2018.

10.

An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease.

Kik SV, Schumacher S, Cirillo DM, Churchyard G, Boehme C, Goletti D, Rangaka MX, Denkinger CM, Lienhardt C, Gilpin C, Matteelli A, Cobelens F.

Eur Respir J. 2018 Oct 25;52(4). pii: 1800946. doi: 10.1183/13993003.00946-2018. Print 2018 Oct.

PMID:
30139776
11.

Defining a migrant-inclusive tuberculosis research agenda to end TB.

Shete PB, Boccia D, Dhavan P, Gebreselassie N, Lönnroth K, Marks S, Matteelli A, Posey DL, van der Werf MJ, Winston CA, Lienhardt C.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):835-843. doi: 10.5588/ijtld.17.0503. Erratum in: Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1244.

12.

Implementation of tuberculosis prevention for exposed children, Burkina Faso.

Sulis G, Combary A, Getahun H, Gnanou S, Giorgetti PF, Konseimbo A, Capone S, Hamada Y, Baddeley A, Matteelli A.

Bull World Health Organ. 2018 Jun 1;96(6):386-392. doi: 10.2471/BLT.17.201343. Epub 2018 Apr 20.

13.

Tuberculosis elimination: where are we now?

Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, Centis R, D'Ambrosio L, Visca D, Spanevello A, Battista Migliori G.

Eur Respir Rev. 2018 Jun 13;27(148). pii: 180035. doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30. Review.

14.

Towards tackling tuberculosis in vulnerable groups in the European Union: the E-DETECT TB consortium.

Abubakar I, Matteelli A, de Vries G, Zenner D, Cirillo DM, Lönnroth K, Popescu G, Barcellini L, Story A, Migliori GB.

Eur Respir J. 2018 May 10;51(5). pii: 1702604. doi: 10.1183/13993003.02604-2017. Print 2018 May. No abstract available.

PMID:
29748241
15.

Cervical Human Papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study.

Orlando G, Bianchi S, Fasolo MM, Mazza F, Frati ER, Rizzardini G, Matteelli A, Zanchetta N, Amendola A, Tanzi E.

J Prev Med Hyg. 2017 Dec 30;58(4):E259-E265. doi: 10.15167/2421-4248/jpmh2017.58.4.804. eCollection 2017 Dec.

16.

The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review.

Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, van der Werf MJ, Noori T, Pottie K, Matteelli A, Zenner D, Morton RL.

Euro Surveill. 2018 Apr;23(14). doi: 10.2807/1560-7917.ES.2018.23.14.17-00543.

17.

The effectiveness and cost-effectiveness of screening for active tuberculosis among migrants in the EU/EEA: a systematic review.

Greenaway C, Pareek M, Abou Chakra CN, Walji M, Makarenko I, Alabdulkarim B, Hogan C, McConnell T, Scarfo B, Christensen R, Tran A, Rowbotham N, Noori T, van der Werf MJ, Pottie K, Matteelli A, Zenner D, Morton RL.

Euro Surveill. 2018 Apr;23(14). doi: 10.2807/1560-7917.ES.2018.23.14.17-00542.

18.

Policies and practices on the programmatic management of LTBI: a survey in the African Region.

Sulis G, Carvalho ACC, Capone S, Hamada Y, Giorgetti PF, da Silva Martins P, Getahun H, Matteelli A.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):158-164. doi: 10.5588/ijtld.17.0563.

PMID:
29506611
19.

Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting.

Sulis G, Agliati A, Pinsi G, Bozzola G, Foccoli P, Gulletta M, Caligaris S, Tomasoni LR, El-Hamad I, Matteelli A.

Eur Respir J. 2018 Mar 22;51(3). pii: 1702345. doi: 10.1183/13993003.02345-2017. Print 2018 Mar. No abstract available.

PMID:
29439018
20.

Tuberculosis elimination: a dream or a reality? The case of Oman.

Al Yaquobi F, Al-Abri S, Al-Abri B, Al-Abaidani I, Al-Jardani A, D'Ambrosio L, Centis R, Matteelli A, Manissero D, Migliori GB.

Eur Respir J. 2018 Jan 11;51(1). pii: 1702027. doi: 10.1183/13993003.02027-2017. Print 2018 Jan. No abstract available.

PMID:
29326321
21.

Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.

Pittalis S, Piselli P, Contini S, Gualano G, Alma MG, Tadolini M, Piccioni P, Bocchino M, Matteelli A, Bonora S, Di Biagio A, Franzetti F, Carbonara S, Gori A, Sotgiu G, Palmieri F, Ippolito G, Girardi E.

PLoS One. 2017 Dec 18;12(12):e0189425. doi: 10.1371/journal.pone.0189425. eCollection 2017.

22.

Time trend analysis (2009-2016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy.

Stefanelli P, Vescio MF, Landini MP, Dal Conte I, Matteelli A, Cristaudo A, Gaino M, Cusini M, Barbui AM, Mencacci A, De Nittis R, Ghisetti V, Stroppiana E, Carannante A; Neisseria gonorrhoeae antimicrobials resistant Study Group.

PLoS One. 2017 Dec 14;12(12):e0189484. doi: 10.1371/journal.pone.0189484. eCollection 2017.

23.

Imported malaria in northern Italy: epidemiology and clinical features observed over 18 years in the Teaching Hospital of Brescia.

Zanotti P, Odolini S, Tomasoni LR, Grecchi C, Caligaris S, Gulletta M, Matteelli A, Cappa V, Castelli F.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tax081.

PMID:
29232457
24.

Tailoring Treatment of Latent Tuberculosis to the Needs of Patients and Families.

Getahun H, Matteelli A.

Ann Intern Med. 2017 Nov 21;167(10):742-743. doi: 10.7326/M17-2639. Epub 2017 Nov 7. No abstract available. Erratum in: Ann Intern Med. 2018 Jan 2;168(1):84.

PMID:
29114744
25.

Antiretroviral Therapy in HIV-Infected Children With Tuberculosis: A Systematic Review.

Sulis G, Amadasi S, Odone A, Penazzato M, Matteelli A.

Pediatr Infect Dis J. 2018 May;37(5):e117-e125. doi: 10.1097/INF.0000000000001784.

PMID:
28902004
26.

Methodological considerations for economic modelling of latent tuberculous infection screening in migrants.

Shedrawy J, Siroka A, Oxlade O, Matteelli A, Lönnroth K.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):977-989. doi: 10.5588/ijtld.17.0134. Review.

PMID:
28826446
27.

Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.

Zenner D, Hafezi H, Potter J, Capone S, Matteelli A.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):965-976. doi: 10.5588/ijtld.16.0935. Review.

PMID:
28826445
28.

A Strange Manifestation of Malaria in a Native Nigerian Boy.

Magro P, Izzo I, Saccani B, Casari S, Caligaris S, Tomasoni LR, Matteelli A, Lombardi A, Meini A, Castelli F.

Mediterr J Hematol Infect Dis. 2017 Mar 1;9(1):e2017023. doi: 10.4084/MJHID.2017.023. eCollection 2017.

29.

Tuberculosis elimination and the challenge of latent tuberculosis.

Matteelli A, Sulis G, Capone S, D'Ambrosio L, Migliori GB, Getahun H.

Presse Med. 2017 Mar;46(2 Pt 2):e13-e21. doi: 10.1016/j.lpm.2017.01.015. Epub 2017 Mar 6. Review.

PMID:
28279508
30.

Breaking the barriers: Migrants and tuberculosis.

Sotgiu G, Dara M, Centis R, Matteelli A, Solovic I, Gratziou C, Rendon A, Battista Migliori G.

Presse Med. 2017 Mar;46(2 Pt 2):e5-e11. doi: 10.1016/j.lpm.2017.01.013. Epub 2017 Feb 28. Review.

PMID:
28256381
31.

Tuberculosis-a World Health Organization Perspective.

Sotgiu G, Sulis G, Matteelli A.

Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0036-2016. Review.

PMID:
28185618
32.

Louse-borne relapsing fever in a refugee from Mali.

Grecchi C, Zanotti P, Pontarelli A, Chiari E, Tomasoni LR, Gulletta M, Barbui A, Caligaris S, Matteelli A, Castelli F.

Infection. 2017 Jun;45(3):373-376. doi: 10.1007/s15010-017-0987-2. Epub 2017 Feb 4.

PMID:
28161771
33.

Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries.

Blasi F, Matteelli A, Sotgiu G, Cirillo DM, Palmieri F, Fattorini L, Migliori GB.

Eur Respir J. 2017 Feb 2;49(2). pii: 1602242. doi: 10.1183/13993003.02242-2016. Print 2017 Feb. No abstract available.

34.

Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research Initiative.

Neumayr A, Muñoz J, Schunk M, Bottieau E, Cramer J, Calleri G, López-Vélez R, Angheben A, Zoller T, Visser L, Serre-Delcor N, Genton B, Castelli F, Van Esbroeck M, Matteelli A, Rochat L, Sulleiro E, Kurth F, Gobbi F, Norman F, Torta I, Clerinx J, Poluda D, Martinez M, Calvo-Cano A, Sanchez-Seco MP, Wilder-Smith A, Hatz C, Franco L; for TropNet.

Euro Surveill. 2017 Jan 5;22(1). pii: 30433. doi: 10.2807/1560-7917.ES.2017.22.1.30433.

35.

From latent to patent: rethinking prediction of tuberculosis.

Cobelens F, Kik S, Esmail H, Cirillo DM, Lienhardt C, Matteelli A.

Lancet Respir Med. 2017 Apr;5(4):243-244. doi: 10.1016/S2213-2600(16)30419-2. Epub 2016 Dec 22. No abstract available.

PMID:
28017341
36.

Policies and practices on the programmatic management of latent tuberculous infection: global survey.

Hamada Y, Sidibe A, Matteelli A, Dadu A, Aziz MA, Del Granado M, Nishikiori N, Floyd K, Getahun H.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1566-1571.

PMID:
27931330
37.

Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe.

Matteelli A, Centis R, Sulis G, Tadolini M.

Travel Med Infect Dis. 2016 Nov - Dec;14(6):588-590. doi: 10.1016/j.tmaid.2016.11.017. Epub 2016 Nov 30.

PMID:
27913312
38.

Recent developments in the diagnosis and management of tuberculosis.

Sulis G, Centis R, Sotgiu G, D'Ambrosio L, Pontali E, Spanevello A, Matteelli A, Zumla A, Migliori GB.

NPJ Prim Care Respir Med. 2016 Nov 3;26:16078. doi: 10.1038/npjpcrm.2016.78. Review.

39.

Assessing the impact of defining a global priority research agenda to address HIV-associated tuberculosis.

Odone A, Matteelli A, Chiesa V, Cella P, Ferrari A, Pezzetti F, Signorelli C, Getahun H.

Trop Med Int Health. 2016 Nov;21(11):1420-1427. doi: 10.1111/tmi.12768. Epub 2016 Aug 31. Review.

40.

The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.

Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D.

Lancet Infect Dis. 2016 Nov;16(11):1269-1278. doi: 10.1016/S1473-3099(16)30216-X. Epub 2016 Aug 10. Review.

PMID:
27522233
41.

Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.

Sulis G, Gnanou S, Roggi A, Konseimbo A, Giorgetti PF, Castelli F, Matteelli A.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1306-1308.

PMID:
27725039
42.

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use.

Gualano G, Capone S, Matteelli A, Palmieri F.

Infect Dis Rep. 2016 Jun 24;8(2):6569. doi: 10.4081/idr.2016.6569. eCollection 2016 Jun 24. Review.

43.

Rifampicin resistance after treatment for latent tuberculous infection: a systematic review and meta-analysis.

den Boon S, Matteelli A, Getahun H.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1065-71. doi: 10.5588/ijtld.15.0908. Review.

44.

Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy.

Carannante A, Vacca P, Ghisetti V, Latino MA, Cusini M, Matteelli A, Vocale C, Prignano G, Leli C, Ober P, Antonetti R, Poletti F, Stefanelli P.

Microb Drug Resist. 2017 Mar;23(2):247-252. doi: 10.1089/mdr.2016.0086. Epub 2016 Jun 27.

PMID:
27347854
45.

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.

Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB.

Eur Respir J. 2016 Sep;48(3):938-43. doi: 10.1183/13993003.00705-2016. Epub 2016 Jun 23. No abstract available.

46.

WHO strategies for the programmatic management of drug-resistant tuberculosis.

Matteelli A, Centis R, D'Ambrosio L, Sotgiu G, Tadolini M, Pontali E, Spanevello A, Migliori GB.

Expert Rev Respir Med. 2016 Sep;10(9):991-1002. doi: 10.1080/17476348.2016.1199278. Epub 2016 Jun 22. Review.

PMID:
27276361
47.

The Holy Grail of prevention of sexually transmitted infections in travellers.

Matteelli A, Capone S.

Sex Transm Infect. 2016 Sep;92(6):405-6. doi: 10.1136/sextrans-2016-052573. Epub 2016 Jun 6. No abstract available.

PMID:
27272531
48.

Advancing global programmatic management of latent tuberculosis infection for at risk populations.

Getahun H, Matteelli A, Abubakar I, Hauer B, Pontali E, Migliori GB.

Eur Respir J. 2016 May;47(5):1327-30. doi: 10.1183/13993003.00449-2016. No abstract available.

49.

Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials.

Borges ÁH, Lundh A, Tendal B, Bartlett JA, Clumeck N, Costagliola D, Daar ES, Echeverría P, Gisslén M, Huedo-Medina TB, Hughes MD, Huppler Hullsiek K, Khabo P, Komati S, Kumar P, Lockman S, MacArthur RD, Maggiolo F, Matteelli A, Miro JM, Oka S, Petoumenos K, Puls RL, Riddler SA, Sax PE, Sierra-Madero J, Torti C, Lundgren JD.

Clin Infect Dis. 2016 Jul 15;63(2):268-80. doi: 10.1093/cid/ciw236. Epub 2016 Apr 18. Review.

50.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Jun;47(6):1758-66. doi: 10.1183/13993003.00214-2016. Epub 2016 Apr 13.

Supplemental Content

Loading ...
Support Center